Chenbo Ding

1.2k total citations
22 papers, 851 citations indexed

About

Chenbo Ding is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Chenbo Ding has authored 22 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Chenbo Ding's work include Protein Tyrosine Phosphatases (5 papers), RNA modifications and cancer (5 papers) and Peptidase Inhibition and Analysis (5 papers). Chenbo Ding is often cited by papers focused on Protein Tyrosine Phosphatases (5 papers), RNA modifications and cancer (5 papers) and Peptidase Inhibition and Analysis (5 papers). Chenbo Ding collaborates with scholars based in China, United States and United Kingdom. Chenbo Ding's co-authors include Xiaobo Fan, Guoqiu Wu, Junmin Luo, Jihong Feng, Guoqiu Wu, Huabing Li, Longmei Li, Weina Yu, Youqiong Ye and Richard A. Flavell and has published in prestigious journals such as Science Advances, Carcinogenesis and Cancer Letters.

In The Last Decade

Chenbo Ding

21 papers receiving 848 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chenbo Ding China	15	664	297	170	103	75	22	851
Zhigao Li China	15	504 0.8×	374 1.3×	211 1.2×	128 1.2×	73 1.0×	28	825
Tianli Fan China	14	609 0.9×	391 1.3×	167 1.0×	62 0.6×	92 1.2×	29	832
Xin Song China	16	662 1.0×	385 1.3×	211 1.2×	94 0.9×	120 1.6×	31	921
Qianqian Lei China	16	514 0.8×	333 1.1×	213 1.3×	145 1.4×	82 1.1×	39	831
Sima Orouei Iran	16	571 0.9×	379 1.3×	167 1.0×	72 0.7×	89 1.2×	19	848
Jing‐Yu Lang China	14	607 0.9×	202 0.7×	202 1.2×	71 0.7×	56 0.7×	23	803
Xi Yu China	15	410 0.6×	227 0.8×	162 1.0×	71 0.7×	101 1.3×	43	747
Souzan Najafi Iran	15	416 0.6×	254 0.9×	226 1.3×	92 0.9×	75 1.0×	35	726
Pingli Mo China	16	576 0.9×	289 1.0×	171 1.0×	85 0.8×	78 1.0×	37	789

Countries citing papers authored by Chenbo Ding

Since Specialization

Citations

This map shows the geographic impact of Chenbo Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenbo Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenbo Ding more than expected).

Fields of papers citing papers by Chenbo Ding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenbo Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenbo Ding. The network helps show where Chenbo Ding may publish in the future.

Co-authorship network of co-authors of Chenbo Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Chenbo Ding. A scholar is included among the top collaborators of Chenbo Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenbo Ding. Chenbo Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ding, Chenbo, Hua Liu, Manolis Roulis, et al.. (2025). METTL3 modulates colonic epithelium integrity via maintaining the self-renewal and differentiation of Lgr5+ stem cell. Journal of Molecular Cell Biology. 17(2). 1 indexed citations

Xu, Binghe, Chenbo Ding, Yilong Liu, et al.. (2025). HNF4α inhibits the malignancy of intrahepatic cholangiocarcinoma by suppressing the Wnt signaling pathway. Translational Oncology. 53. 102290–102290.

Zhao, Jiachen, Chenbo Ding, & Huabing Li. (2023). N⁶‐ Methyladenosine defines a new checkpoint in γδ T cell development. BioEssays. 45(5). e2300002–e2300002. 4 indexed citations

Wang, Xindi, Chenbo Ding, & Huabing Li. (2023). The crosstalk between enteric nervous system and immune system in intestinal development, homeostasis and diseases. Science China Life Sciences. 67(1). 41–50. 12 indexed citations

Ding, Chenbo, Zhibin Yu, Esen Sefik, et al.. (2023). A Treg-specific long noncoding RNA maintains immune-metabolic homeostasis in aging liver. Nature Aging. 3(7). 813–828. 17 indexed citations

Ding, Chenbo, Jun Zhao, Yajuan Hao, et al.. (2022). m ⁶ A mRNA modification maintains colonic epithelial cell homeostasis via NF-κB–mediated antiapoptotic pathway. Science Advances. 8(12). eabl5723–eabl5723. 58 indexed citations

Zhou, Jing, Xingli Zhang, Jiajia Hu, et al.. (2021). m ⁶ A demethylase ALKBH5 controls CD4 ⁺ T cell pathogenicity and promotes autoimmunity. Science Advances. 7(25). 135 indexed citations

Wu, Hailu, Ming Wei, Xinglu Jiang, et al.. (2020). lncRNA PVT1 Promotes Tumorigenesis of Colorectal Cancer by Stabilizing miR-16-5p and Interacting with the VEGFA/VEGFR1/AKT Axis. Molecular Therapy — Nucleic Acids. 20. 438–450. 72 indexed citations

Yang, Liwen, Fangfang Duan, Yuehong Li, et al.. (2020). The effects of CTX damage or inhibition of bone marrow hematopoiesis and GM-CSF stimulation of bone marrow hematopoiesis on the peripheral blood TCRβ CDR3 repertoire of BALB/c mice. Immunopharmacology and Immunotoxicology. 42(2). 110–118. 4 indexed citations

10.

Yang, Liwen, Min Liu, Yanjie Zhou, et al.. (2019). <p>INPP4B inhibits cell proliferation, invasion and chemoresistance in human hepatocellular carcinoma</p>. OncoTargets and Therapy. Volume 12. 3491–3507. 14 indexed citations

11.

Yang, Liwen, Chenbo Ding, Min Liu, et al.. (2019). INPP4B exerts a dual function in the stemness of colorectal cancer stem-like cells through regulating Sox2 and Nanog expression. Carcinogenesis. 41(1). 78–90. 15 indexed citations

12.

Ding, Chenbo, Hailu Wu, Xiaobo Fan, et al.. (2018). The PEAK1–PPP1R12B axis inhibits tumor growth and metastasis by regulating Grb2/PI3K/Akt signalling in colorectal cancer. Cancer Letters. 442. 383–395. 41 indexed citations

13.

Ding, Chenbo, Xiaobo Fan, Xiyong Wang, et al.. (2018). Overexpression of PEAK1 contributes to epithelial–mesenchymal transition and tumor metastasis in lung cancer through modulating ERK1/2 and JAK2 signaling. Cell Death and Disease. 9(8). 802–802. 43 indexed citations

14.

Ding, Chenbo, et al.. (2018). Intestinal microbiota: a novel perspective in colorectal cancer biotherapeutics. OncoTargets and Therapy. Volume 11. 4797–4810. 43 indexed citations

15.

Zhu, Xiaoli, Hongming Zhang, Xiaobo Fan, et al.. (2017). ERCC1_202 Is A Prognostic Biomarker in Advanced Stage Non-Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy. Journal of Cancer. 8(14). 2846–2853. 8 indexed citations

16.

Ding, Chenbo, Junmin Luo, Xiaobo Fan, et al.. (2017). Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels. Journal of Experimental & Clinical Cancer Research. 36(1). 32 indexed citations

17.

Ding, Chenbo, Junmin Luo, Longmei Li, et al.. (2016). Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancer. Journal of Experimental & Clinical Cancer Research. 35(1). 5–5. 64 indexed citations

18.

Ding, Chenbo, et al.. (2016). Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model. BMC Cancer. 16(1). 791–791. 43 indexed citations

19.

Ding, Chenbo, Xiaobo Fan, & Guoqiu Wu. (2016). Peroxiredoxin 1 – an antioxidant enzyme in cancer. Journal of Cellular and Molecular Medicine. 21(1). 193–202. 170 indexed citations

20.

Ding, Chenbo, Weina Yu, Jihong Feng, & Junmin Luo. (2015). Structure and function of Gab2 and its role in cancer (Review). Molecular Medicine Reports. 12(3). 4007–4014. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact